insights_auto
Why is NEUP down 2.75%?
Dive Deeperchevron_right
NEUP:NASDAQ
Neuphoria Therapeutics Inc
$2.48
arrow_downward
-2.75%(-0.070) 1D
$2.52
arrow_upward
+1.43% (+0.036)bedtimeAfter hours
Closed: Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEUP...
Open
$2.50
High
$2.54
Low
$2.45
Mkt. cap
13.42M
Avg. vol.
30.32K
Volume
23.42K
52-wk high
$5.53
52-wk low
$2.45
EPS
-$3.06
Shares outstanding
5.41M
No. of employees
1
Open
$2.50
High
$2.54
Low
$2.45
Mkt. cap
13.42M
Avg. vol.
30.32K
Volume
23.42K
52-wk high
$5.53
52-wk low
$2.45
EPS
-$3.06
Shares outstanding
5.41M
No. of employees
1
News stories
From web sources and news partners
TradingView
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
9 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
14 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
Traders Union
·
6 hours ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
About Neuphoria Therapeutics Inc
CEO-
Employees1
Founded1996
HeadquartersMillis, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteneuphoriatx.com